Xalvobin 500 mg Filmdragerad tablett

Država: Švedska

Jezik: švedski

Izvor: Läkemedelsverket (Medical Products Agency)

Kupi sada

Preuzimanje Uputa o lijeku (PIL)
25-04-2018
Preuzimanje Svojstava lijeka (SPC)
25-04-2018

Aktivni sastojci:

kapecitabin

Dostupno od:

Alvogen IPCo S.ar.l

ATC koda:

L01BC06

INN (International ime):

capecitabine

Doziranje:

500 mg

Farmaceutski oblik:

Filmdragerad tablett

Sastav:

kapecitabin 500 mg Aktiv substans

Razred:

Apotek

Tip recepta:

Receptbelagt

Područje terapije:

Kapecitabin

Proizvod sažetak:

Förpacknings: Blister, 120 tabletter

Status autorizacije:

Godkänd

Datum autorizacije:

2012-08-23

Uputa o lijeku

                                PACKAGE LEAFLET
PACKAGE LEAFLET: INFORMATION FOR THE USER
XALVOBIN 150 MG FILM-COATED TABLETS
XALVOBIN 500 MG FILM-COATED TABLETS
capecitabine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Xalvobin is and what it is used for
2.
What you need to know before you take Xalvobin
3.
How to take Xalvobin
4.
Possible side effects
5.
How to store Xalvobin
6.
Contents of the pack and other information
1.
WHAT XALVOBIN IS AND WHAT IT IS USED FOR
Xalvobin belongs to the group of medicines called "cytostatic
medicines", which stop the growth of
cancer cells. Xalvobin contains 150 mg capecitabine, which itself is
not a cytostatic medicine. Only
after being absorbed by the body is it changed into an active
anti-cancer medicine (more in tumour
tissue than in normal tissue).
Xalvobin belongs to the group of medicines called "cytostatic
medicines", which stop the growth of
cancer cells. Xalvobin contains 500 mg capecitabine, which itself is
not a cytostatic medicine. Only
after being absorbed by the body is it changed into an active
anti-cancer medicine (more in tumour
tissue than in normal tissue).
Xalvobin is used in the treatment of colon, rectal, gastric, or breast
cancers. Furthermore, Xalvobin is
used to prevent new occurrence of colon cancer after complete removal
of the tumour by surgery.
Xalvobin may be used either alone or in combination with other
medicines.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE XALVOBIN
DO NOT TAKE XALVOBIN
-
If you are allergic to capecitabine or any of the other ingredients of

                                
                                Pročitajte cijeli dokument
                                
                            

Svojstava lijeka

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Pročitajte cijeli dokument
                                
                            

Dokumenti na drugim jezicima

Uputa o lijeku Uputa o lijeku engleski 18-01-2022
Svojstava lijeka Svojstava lijeka engleski 18-01-2022
Izvješće o ocjeni javnog Izvješće o ocjeni javnog engleski 18-02-2013